Molecular basis for impaired collateral artery growth in the spontaneously hypertensive rat: Insight from microarray analysis

Physiological Reports

Volumn 1, Issue 2, 2013, Pages

  Unthank, Joseph L ^a   McClintick, Jeanette N ^a   Labarrere, Carlos A ^a,b   Li, Lang ^a   Distasi, Matthew R ^a   Miller, Steven J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY HEALTH   (United States)

Author keywords

Arteriogenesis; Collateral gene expression; Microarray analysis; Peripheral vascular disease

Indexed keywords

3BETA HYDROXY DELTA5 STEROID DEHYDROGENASE; A KINASE ANCHOR PROTEIN 11; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALPHA7 INTEGRIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; APOCYNIN; ARGININE TRANSPORTER SOLUTE CARRIER FAMILY 7; CYSTATIN C; ELONGATION FACTOR G; ENOYL COENZYME A HYDRATASE; FRACTALKINE; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1BETA; ISOVALERYL COENZYME A DEHYDROGENASE; LOSARTAN; N ETHYLMALEIMIDE SENSITIVE FACTOR ATTACHMENT PROTEIN ALPHA; NITRIC OXIDE; PEPTIDES AND PROTEINS; PROTEIN C JUN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SMALL INTERFERING RNA; TAURINE TRANSPORTER; THY 1 ANTIGEN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; COLLATERAL ARTERY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE TRANSLOCATION; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; NONHUMAN; OXIDATION REDUCTION STATE; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; TISSUE GROWTH; TRANSCRIPTION REGULATION; UPREGULATION; WISTAR KYOTO RAT;

EID: 85008870526     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.1002/phy2.5     Document Type: Article

References (91)

1. Ahimastos, A. A., A. Lawler, C. M. Reid, P. A. Blombery, and B. A. Kingwell. 2006. Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial. Ann. Intern. Med. 144: 660–664.
2. Aitkenhead, M., S. J. Wang, M. N. Nakatsu, J. Mestas, C. Heard, and C. C. Hughes. 2002. Identification of endothelial cell genes expressed in an in vitro model of angiogenesis: induction of ESM-1, (beta) ig-h3, and NrCAM. Microvasc. Res. 63: 159–171.
3. Allen, R. G., and M. Tresini. 2000. Oxidative stress and gene regulation. Free Radic. Biol. Med. 28: 463–499.
4. Bechard, D., A. Scherpereel, H. Hammad, T. Gentina, A. Tsicopoulos, M. Aumercier, et al. 2001. Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J. Immunol. 167: 3099–3106.
5. Bechard, D., T. Gentina, M. Delehedde, A. Scherpereel, M. Lyon, M. Aumercier, et al. 2001. Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J. Biol. Chem. 276: 48341–48349.
6. Bird, I. M., J. Zheng, J. M. Cale, and R. R. Magness. 1997. Pregnancy induces an increase in angiotensin II type-1 receptor expression in uterine but not systemic artery endothelium. Endocrinology 138: 490–498.
7. Borghese, F., and F. I. Clanchy. 2011. CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease. Expert Opin. Ther. Targets 15: 237–251.
8. Briones, A. M., M. J. Alonso, J. Marin, G. Balfagon, and M. Salaices. 2000. Influence of hypertension on nitric oxide synthase expression and vascular effects of lipopolysaccharide in rat mesenteric arteries. Br. J. Pharmacol. 131: 185–194.
9. Bruemmer, D., F. Blaschke, and R. E. Law. 2005. New targets for PPAR[gamma] in the vessel wall: implications for restenosis. Int. J. Obes. Relat. Metab. Disord. 29: S26–S30.
10. Castier, Y., B. Ramkhelawon, S. Riou, A. Tedgui, and S. Lehoux. 2009. Role of NF-kappaB in flow-induced vascular remodeling. Antioxid. Redox Signal. 11: 1641–1649.
11. Ceyhan, K., H. Kadi, A. Celik, T. Burucu, F. Koc, E. Sogut, et al. 2012. Angiotensin-converting enzyme DD polymorphism is associated with poor coronary collateral circulation in patients with coronary artery disease. J. Investig. Med. 60: 49–55.
12. Chen, Z., J. Rubin, and E. Tzima. 2010. Role of PECAM-1 in arteriogenesis and specification of preexisting collaterals. Circ. Res. 107: 1355–1363.
13. Dai, X., and J. E. Faber. 2010. Endothelial nitric oxide synthase deficiency causes collateral vessel rarefaction and impairs activation of a cell cycle gene network during arteriogenesis. Circ. Res. 106: 1870–1881.
14. Dai, G., S. Vaughn, Y. Zhang, E. T. Wang, G. Garcia-Cardena, and M. A. Gimbrone. 2007. Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2. Circ. Res. 101: 723–733.
15. Davis, M. E., I. M. Grumbach, T. Fukai, A. Cutchins, and D. G. Harrison. 2004. Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor jB binding. J. Biol. Chem. 279: 163–168.
16. Distasi, M. R., J. Case, M. A. Ziegler, M. C. Dinauer, M. C. Yoder, L. S. Haneline, et al. 2009. Suppressed hindlimb perfusion in Rac2-/-and Nox2-/-mice does not result from impaired collateral growth. Am. J. Physiol. Heart Circ. Physiol. 296: H877–H886.
17. Du, X., K. Stocklauser-Farber, and P. Rosen. 1999. Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? Free Radic. Biol. Med. 27: 752–763.
18. Emanueli, C., M. B. Salis, T. Stacca, L. Gaspa, J. Chao, L. Chao, et al. 2001. Rescue of impaired angiogenesis in spontaneously hypertensive rats by intramuscular human tissue kallikrein gene transfer. Hypertension 38: 136–141.
19. Emanueli, C., M. B. Salis, T. Stacca, A. Pinna, L. Gaspa, A. Spano, et al. 2002. Ramipril improves hemodynamic recovery but not microvascular response to ischemia in spontaneously hypertensive rats. Am. J. Hypertens. 15: 410–415.
20. Fan, H., P. Hall, L. L. Santos, J. L. Gregory, G. Fingerle-Rowson, R. Bucala, et al. 2011. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase. J. Immunol. 186: 4915–4924.
21. Flescher, E., H. Tripoli, K. Salnikow, and F. J. Burns. 1998. Oxidative stress suppresses transcription factor activities in stimulated lymphocytes. Clin. Exp. Immunol. 112: 242–247.
22. Gornik, H. L. 2009. Rethinking the morbidity of peripheral arterial disease and the “normal” ankle-brachial index. J. Am. Coll. Cardiol. 53: 1063–1064.
23. Graham, D., N. N. Huynh, C. A. Hamilton, E. Beattie, R. A. J. Smith, H. M. Cocheme, et al. 2009. Mitochondriatargeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 54: 322–328.
24. Green, S. R., K. H. Han, Y. Chen, F. Almazan, I. F. Charo, Y. I. Miller, et al. 2006. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK. J. Immunol. 176: 7412–7420.
25. Grumbach, I. M., W. Chen, S. A. Mertens, and D. G. Harrison. 2005. A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription. J. Mol. Cell. Cardiol. 39: 595–603.
26. Haas, T. L., J. L. Doyle, M. R. Distasi, L. E. Norton, K. M. Sheridan, and J. L. Unthank. 2007. Involvement of MMPs in the outward remodeling of collateral mesenteric arteries. Am. J. Physiol. Heart Circ. Physiol. 293: H2429–H2437.
27. Herzog, S., H. Sager, E. Khmelevski, A. Deylig, and W. D. Ito. 2002. Collateral arteries grow from preexisting anastomoses in the rat hindlimb. Am. J. Physiol. Heart Circ. Physiol. 283: H2012–H2020.
28. Hirsch, A. T., Z. J. Haskal, N. R. Hertzer, C. W. Bakal, M. A. Creager, J. L. Halperin, et al. 2006. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)-summary of recommendations. J. Vasc. Interv. Radiol. 17: 1383–1397.
29. Hochberg, I., A. Roguin, E. Nikolsky, P. V. Chanderashekhar, S. Cohen, and A. P. Levy. 2002. Haptoglobin phenotype and coronary artery collaterals in diabetic patients. Atherosclerosis 161: 441–446.
30. Iaccarino, G., M. Ciccarelli, D. Sorriento, G. Galasso, A. Campanile, G. Santulli, et al. 2005. Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ. Res. 97: 1182–1189.
31. Ichiki, T., M. Usui, M. Kato, Y. Funakoshi, K. Ito, K. Egashira, et al. 1998. Downregulation of angiotensin II type 1 receptor gene transcription by nitric oxide. Hypertension 31: 342–346.
32. Kelm, M., M. Feelisch, T. Krebber, A. Deußen, W. Motz, and B. E. Strauer. 1995. Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats. Maintenance of nitric oxide-forming capacity and increased basal production of nitric oxide. Hypertension 25: 186–193.
33. Khachigian, L. M., N. Resnick, M. A. Gimbrone Jr, and T. Collins. 1995. Nuclear factor-K B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. J. Clin. Invest. 96: 1169–1175.
34. Kinnaird, T., E. Stabile, S. Zbinden, M.-S. Burnett, and S. E. Epstein. 2008. Cardiovascular risk factors impair native collateral development and may impair efficacy of therapeutic interventions. Cardiovasc. Res. 78: 257–264.
35. Lan, Q. X., K. O. Mercurius, and P. F. Davies. 1994. Stimulation of transcription factors NFjB and AP1 in endothelial cells subjected to shear stress. Biochem. Biophys. Res. Commun. 201: 950–956.
36. Lee, C. W., E. Stabile, T. Kinnaird, M. Shou, J. M. Devaney, S. E. Epstein, et al. 2004. Temporal patterns of gene expression after acute hindlimb ischemia in mice: insights into the genomic program for collateral vessel development. J. Am. Coll. Cardiol. 43: 474–482.
37. Liu, Y., M. W. Taylor, and H. J. Edenberg. 2006. Model-based identification of cis-acting elements from microarray data. Genomics 88: 452–461.
38. Longland, C. J. 1953. The collateral circulation of the limb. Ann. R. Coll. Surg. Engl. 13: 161–176.
39. Maffei, A., R. Poulet, C. Vecchione, S. Colella, L. Fratta, G. Frati, et al. 2002. Increased basal nitric oxide release despite enhanced free radical production in hypertension. J. Hypertens. 20: 1135–1142.
40. Masuda, H., K. Kawamura, K. Tohda, T. Shozawa, M. Sageshima, and A. Kamiya. 1989. Increase in endothelial cell density before artery enlargement in flow-loaded canine carotid artery. Atherosclerosis 9: 812–823.
41. Matrougui, K., J. Maclouf, B. I. Levy, and D. Henrion. 1997. Impaired nitric oxide-and prostaglandin-mediated responses to flow in resistance arteries of hypertensive rats. Hypertension 30: 942–947.
42. Matsumura, M., N. Fukuda, N. Kobayashi, H. Umezawa, A. Takasaka, T. Matsumoto, et al. 2009. Effects of atorvastatin on angiogenesis in hindlimb ischemia and endothelial progenitor cell formation in rats. J. Atheroscler. Thromb. 16: 319–326.
43. Matthews, J. R., C. H. Botting, M. Panico, H. R. Morris, and R. T. Hay. 1996. Inhibition of NF-jB DNA binding by nitric oxide. Nucleic Acids Res. 24: 2236–2242.
44. McClintick, J. N., R. E. Jerome, C. R. Nicholson, D. W. Crabb, and H. J. Edenberg. 2003. Reproducibility of oligonucleotide arrays using small samples. BMC Genomics 4: 4.
45. Miller, S. J., L. E. Norton, M. P. Murphy, M. C. Dalsing, and J. L. Unthank. 2007a. The role of the reninangiotensin system and oxidative stress in spontaneously hypertensive rat (SHR) mesenteric collateral growth impairment. Am. J. Physiol. Heart Circ. Physiol. 292: H2523–H2531.
46. Miller, S. J., W. C. Watson, K. A. Kerr, C. A. Labarrere, N. X. Chen, M. A. Deeg, et al. 2007b. Development of progressive aortic vasculopathy in a rat model of aging. Am. J. Physiol. Heart Circ. Physiol. 293: H2634–H2643.
47. Miyashiro, J. K., V. Poppa, and B. C. Berk. 1997. Flowinduced vascular remodeling in the rat carotid artery diminishes with age. Circ. Res. 81: 311–319.
48. Modlinger, P., T. Chabrashvili, P. S. Gill, M. Mendonca, D. G. Harrison, K. K. Griendling, et al. 2006. RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension 47: 238–244.
49. Nava, E., G. Noll, and T. F. Lüscher. 1995. Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation 91: 2310–2313.
50. Nava, E., A. L. Farre, C. Moreno, S. Casado, P. Moreau, F. Cosentino, et al. 1998. Alterations to the nitric oxide pathway in the spontaneously hypertensive rat. J. Hypertens. 16: 609–615.
51. Nelissen-Vrancken, H. J., P. J. Leenders, H. A. Struijker Boudier, and J. F. Smits. 1992. Increased responsiveness of the vascular bed to angiotensin I, angiotensin II and phenylephrine in acute and chronic ischemic hindlimbs in rats. J. Vasc. Res. 29: 359–366.
52. Nelissen-Vrancken, H. J., H. A. Boudier, M. J. Daemen, and J. F. Smits. 1993. Antihypertensive therapy and adaptive mechanisms in peripheral ischemia. Hypertension 22: 780–788.
53. Okamoto, K., and K. Aoki. 1963. Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 27: 282–293.
54. Packham, I. M., C. Gray, P. R. Heath, P. G. Hellewell, P. W. Ingham, D. C. Crossman, et al. 2009. Microarray profiling reveals CXCR4a is downregulated by blood flow in vivo and mediates collateral formation in zebrafish embryos. Physiol. Genomics 38: 319–327.
55. Palm, F., M. L. Onozato, Z. Luo, and C. S. Wilcox. 2007. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am. J. Physiol. Heart Circ. Physiol. 293: H3227–H3245.
56. Piotrkowski, B., O. R. Koch, E. M. V. De Cavanagh, and C. G. Fraga. 2009. Cardiac mitochondrial function and tissue remodelling are improved by a non-antihypertensive dose of enalapril in spontaneously hypertensive rats. Free Radic. Res. 43: 390–399.
57. Potenza, M. A., F. L. Marasciulo, D. M. Chieppa, G. S. Brigiani, G. Formoso, M. J. Quon, et al. 2005. Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am. J. Physiol. Heart Circ. Physiol. 289: H813–H822.
58. Prior, B. M., P. G. Lloyd, J. Ren, H. Li, H. T. Yang, M. H. Laughlin, et al. 2004. Time course of changes in collateral blood flow and isolated vessel size and gene expression after femoral artery occlusion in rats. Am. J. Physiol. Heart Circ. Physiol. 287: H2434–H2447.
59. Pung, Y. F., P. Rocic, M. P. Murphy, R. A. J. Smith, J. Hafemeister, V. Ohanyan, et al. 2012. Resolution of mitochondrial oxidative stress rescues coronary collateral growth in Zucker obese fatty rats. Arterioscler. Thromb. Vasc. Biol. 32: 325–334.
60. Qiu, H. Y., D. Henrion, J. Benessiano, C. Heymes, B. Tournier, and B. I. Levy. 1998. Decreased flow-induced dilation and increased production of cGMP in spontaneously hypertensive rats. Hypertension 32: 1098–1103.
61. Qui, H. Y., D. Henrion, and B. I. Levy. 1994. Alterations in flow-dependent vasomotor tone in spontaneously hypertensive rats. Hypertension 24: 474–479.
62. Rennel, E., S. Mellberg, A. Dimberg, L. Petersson, J. Botling, A. Ameur, et al. 2007. Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer. Exp. Cell Res. 313: 1285–1294.
63. Ryu, J., C.-W. Lee, K.-H. Hong, J.-A. Shin, S.-H. Lim, C.-S. Park, et al. 2008. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Cardiovasc. Res. 78: 333–340.
64. Sarrazin, S., E. Adam, M. Lyon, F. Depontieu, V. Motte, C. Landolfi, et al. 2006. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim. Biophys. Acta 1765: 25–37.
65. Scheidegger, K. J., M. H. Nelissen-Vrancken, P. J. Leenders, M. J. Daemen, J. F. Smits, and J. M. Wood. 1997. Structural adaptation to ischemia in skeletal muscle: effects of blockers of the renin-angiotensin system. J. Hypertens. 15: 1455–1462.
66. Schirmer, S. H., N. van Royen, P. D. Moerland, J. O. Fledderus, J. P. Henriques, R. J. van der Schaaf, et al. 2009. Local cytokine concentrations and oxygen pressure are related to maturation of the collateral circulation in humans. J. Am. Coll. Cardiol. 53: 2141–2147.
67. Sheridan, K. M., M. J. Ferguson, M. R. Distasi, F. A. Witzmann, M. C. Dalsing, S. J. Miller, et al. 2007. Impact of genetic background and aging on mesenteric collateral growth capacity in Fischer 344, Brown Norway, and Fischer 344 x Brown Norway hybrid rats. Am. J. Physiol. Heart Circ. Physiol. 293: H3498–H3505.
68. Sho, E., M. Sho, T. M. Singh, H. Nanjo, M. Komatsu, C. Xu, et al. 2002. Arterial enlargement in response to high flow requires early expression of matrix metalloproteinases to degrade extracellular matrix. Exp. Mol. Pathol. 73: 142–153.
69. Sho, E., M. Komatsu, M. Sho, H. Nanjo, T. M. Singh, C. Xu, et al. 2003. High flow drives vascular endothelial cell proliferation during flow-induced arterial remodeling associated with the expression of vascular endothelial growth factor. Exp. Mol. Pathol. 75: 1–11.
70. Silvestre, J. S., R. Tamarat, T. Senbonmatsu, T. Icchiki, T. Ebrahimian, M. Iglarz, et al. 2002. Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Circ. Res. 90: 1072–1079.
71. Simons, M. 2005. Angiogenesis: where do we stand now? Circulation 111: 1556–1566.
72. Srivastava, S., R. L. Terjung, and H. T. Yang. 2003. Basic fibroblast growth factor increases collateral blood flow in spontaneously hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 285: H1190–H1197.
73. Storey, J. D., and R. Tibshirani. 2003. Statistical significance for genomewide studies. Proc. Natl Acad. Sci. USA 100: 9440–9445.
74. Tamarat, R., J. S. Silvestre, N. Kubis, J. Benessiano, M. Duriez, M. deGasparo, et al. 2002. Endothelial nitric oxide synthase lies downstream from angiotensin ii-induced angiogenesis in ischemic hindlimb. Hypertension 39: 830–835.
75. Troidl, K., S. Tribulova, W. J. Cai, I. Ruding, H. Apfelbeck, W. Schierling, et al. 2010. Effects of endogenous nitric oxide and of DETA NONOate in arteriogenesis. J. Cardiovasc. Pharmacol. 55: 153–160.
76. Tuttle, J. L., K. W. Condict, A. S. Bhuller, R. D. Nachreiner, B. A. Connors, B. P. Herring, et al. 2001. Shear-level influences resistance artery remodeling: wall dimensions, cell density, and eNOS expression. Am. J. Physiol. Heart Circ. Physiol. 281: H1380–H1389.
77. Tuttle, J. L., T. L. Hahn, B. M. Sanders, F. A. Witzmann, S. J. Miller, M. C. Dalsing, et al. 2002a. Impaired collateral development in mature rats. Am. J. Physiol. Heart Circ. Physiol. 283: H146–H155.
78. Tuttle, J. L., B. M. Sanders, H. M. Burkhart, S. W. Fath, B. P. Herring, M. C. Dalsing, et al. 2002b. Impaired collateral artery development in spontaneously hypertensive rats. Microcirculation 9: 343–351.
79. Unthank, J. L., S. W. Fath, H. M. Burkhart, S. Miller, and M. C. Dalsing. 1996a. Wall remodeling during luminal expansion of mesenteric arterial collaterals in the rat. Circ. Res. 79: 1015–1023.
80. Unthank, J. L., T. L. Haas, and S. J. Miller. 2011. Impact of shear level and cardiovascular risk factors on bioavailable nitric oxide and outward vascular remodeling in mesenteric arteries. Pp. 89–119 in E. Deindl and W. Schaper, eds. Arteriogenesis-molecular regulation, pathophysiology, and therapeutics. Shaker Verlag Publishing, Aachen, Germany.
81. Unthank, J. L., J. C. Nixon, H. M. Burkhart, S. W. Fath, and M. C. Dalsing. 1996b. Early collateral and microvascular adaptations to intestinal artery occlusion in the rat. Am. J. Physiol. Heart Circ. Physiol. 271: H914–H923.
82. Vita, J. A., M. Holbrook, J. Palmisano, S. M. Shenouda, W. B. Chung, N. M. Hamburg, et al. 2008. Flow-induced arterial remodeling relates to endothelial function in the human forearm. Circulation 117: 3126–3133.
83. Wahlberg, E. 2003. Angiogenesis and arteriogenesis in limb ischemia. J. Vasc. Surg. 38: 198–203.
84. Warabi, E., W. Takabe, T. Minami, K. Inoue, K. Itoh, M. Yamamoto, et al. 2007. Shear stress stabilizes NF-E2-related factor 2 and induces antioxidant genes in endothelial cells: role of reactive oxygen/nitrogen species. Free Radic. Biol. Med. 42: 260–269.
85. Xu, C., S. Lee, C. Shu, H. Masuda, and C. Zarins. 2002. Expression of TGF-beta1 and beta3 but not apoptosis factors relates to flow-induced aortic enlargement. BMC Cardiovasc. Disord. 2: 11.
86. Yasuda, N., S.-i. Miura, H. Akazawa, T. Tanaka, Y. Qin, Y. Kiya, et al. 2008. Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation. EMBO Rep. 9: 179–186.
87. You, D., C. Cochain, C. Loinard, J. Vilar, B. Mees, M. Duriez, et al. 2008. Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents. Hypertension 51: 1537–1544.
88. Zhan, Q., K. A. Lord, I. Alamo, M. C. Hollander, F. Carrier, D. Ron, et al. 1994. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol. Cell. Biol. 14: 2361–2371.
89. Zhou, X., H. G. Bohlen, S. J. Miller, and J. L. Unthank. 2008. NAD (P) H oxidase-derived peroxide mediates elevated basal and impaired flow-induced NO production in SHR mesenteric arteries in vivo. Am. J. Physiol. Heart Circ. Physiol. 295: H1008–H1016.
90. Zhou, X., H. G. Bohlen, J. L. Unthank, and S. J. Miller. 2009. Abnormal nitric oxide production in aged rat mesenteric arteries is mediated by NAD (P) H oxidasederived peroxide. Am. J. Physiol. Heart Circ. Physiol. 297: H2227–H2233.
91. Ziegler, M. A., M. R. Distasi, R. G. Bills, S. J. Miller, M. Alloosh, M. P. Murphy, et al. 2010. Marvels, mysteries, and misconceptions of vascular compensation to peripheral artery occlusion. Microcirculation 17: 3–20.